A Cleaner Future: Contaminant-Detecting Water Sensor

https://i1.wp.com/f.fastcompany.net/multisite_files/fastcompany/imagecache/1280/poster/2014/05/3030503-poster-p-jack-and-beaker.jpgJack Andraka is at it again! For those who follow this blog (or subscribe to Forbes or watch TED Talks), this young man probably needs no introduction. But if not, then you might not known that Andraka is than the young man who – at 15 years of age – invented an inexpensive litmus test for detecting pancreatic cancer. This invention won him first prize at the 2012 Intel International Science and Engineering Fair (ISEF), and was followed up less than a year later with a handheld device that could detect cancer and even explosives.

And now, Andraka is back with yet another invention: a biosensor that can quickly and cheaply detect water contaminants. His microfluidic biosensor, developed with fellow student Chloe Diggs, recently took the $50,000 first prize among high school entrants in the Siemens We Can Change the World Challenge. The pair developed their credit card-sized biosensor after learning about water pollution in a high school environmental science class.

andraka_diggsAs Andraka explained:

We had to figure out how to produce microfluidic [structures] in a classroom setting. We had to come up with new procedures, and we custom-made our own equipment.

According to Andraka, the device can detect six environmental contaminants: mercury, lead, cadmium, copper, glyphosate, and atrazine. It costs a dollar to make and takes 20 minutes to run, making it 200,000 times cheaper and 25 times more efficient than comparable sensors. At this point, make scaled-down versions of expensive sensors that can save lives has become second nature to Andraka. And in each case, he is able to do it in a way that is extremely cost-effective.

andraka-inlineFor example, Andraka’s litmus test cancer-detector was proven to be 168 times faster than current tests, 90% accurate, and 400 times more sensitive. In addition, his paper test costs 26,000 times less than conventional methods – which include  CT scans, MRIs, Ultrasounds, or Cholangiopancreatography. These tests not only involve highly expensive equipment, they are usually administered only after serious symptoms have manifested themselves.

In much the same vein, Andraka’s handheld cancer/explosive detector was manufactured using simple, off-the-shelf and consumer products. Using a simple cell phone case, a laser pointer and an iPhone camera, he was able to craft a device that does the same job as a raman spectrometer, but at a fraction of the size and cost. Whereas a conventional spectrometer is the size of a room and costs around $100,000, his handheld device is the size of a cell phone and costs $15 worth of components.

andraka_seimensAs part of the project, Diggs and Andraka also developed an inexpensive water filter made out of plastic bottles. Next, they hope to do large-scale testing for their sensor in Maryland, where they live. They also want to develop a cell-phone-based sensor reader that lets users quickly evaluate water quality and post the test results online. Basically, its all part of what is fast becoming the digitization of health and medicine, where the sensors are portable and the information can be uploaded and shared.

This isn’t the only project that Andraka has been working on of late. Along with the two other Intel Science Fair finalists – who came together with him to form Team Gen Z – he’s working on a handheld medical scanner that will be entered in the Tricorder XPrize. This challenge offers $10 million to any laboratory or private inventors that can develop a device that can diagnose 15 diseases in 30 patients over a three-day period. while still being small enough to carry.

For more information on this project and Team Gen Z, check out their website here. And be sure to watch their promotional video for the XPrize competition:


Source:
fastcoexist.com

The Future of Medicine: New Cancer Tests and Treatments

cancer_growingWhile a cure for cancer is still beyond medical science, improvements in how we diagnose and treat the disease are being made every day. These range from early detection, which makes all the difference in preventing the spread of the disease; to less-invasive treatments, which makes for a kinder, gentler recovery. By combining better medicine with cost-saving measures, accessibility is also a possibility.

When it comes to better diagnostics, the aim is to find ways to detect cancer without harmful and expensive scans or exploratory surgery. An alternative is a litmus test, like the one invented by Jack Andraka to detect pancreatic cancer. His method, which was unveiled at the 2012 Intel International Science and Engineering Fair (ISEF), won him the top prize due to the fact that it’s 90% accurate, 168 times faster than current tests and 1/26,000th the cost of regular tests.

cancer_peetestSince that time, Jack and his research group (Generation Z), have been joined by such institutions as MIT, which recently unveiled a pee stick test to detect cancer. In research published late last month in the Proceedings of the National Academy of Sciences, MIT Professor Sangeeta Bhatia reported that she and her team developed paper test strips using the same technology behind in-home pregnancy tests, ones which were able to detect colon tumors in mice.

The test strips work in conjunction with an injection of iron oxide nanoparticles, like those used as MRI contrast agents, that congregate at tumor sites in the body. Once there, enzymes known as matrix metalloproteinases (MMPs), which cancer cells use to invade healthy tissue, break up the nanoparticles, which then pass out through the patient’s urine. Antibodies on the test strip grab them, causing gold nanoparticles to create a red color indicating the presence of the tumor.

cancer_peetest2According to Bhatia, the technology is likely to make a big splash in developing countries where complicated and expensive medical tests are a rarity. Closer to home, the technology is also sure to be of significant use in outpatient clinics and other decentralized health settings. As Bhatia said in a press release:

For the developing world, we thought it would be exciting to adapt (the technology) to a paper test that could be performed on unprocessed samples in a rural setting, without the need for any specialized equipment. The simple readout could even be transmitted to a remote caregiver by a picture on a mobile phone.

To help Bhatia and her research team to bring her idea to fruition, MIT has given her and her team a grant from the university’s Deshpande Center for Technological Innovation. The purpose of the grant is to help the researchers develop a startup that could execute the necessary clinical trials and bring the technology to market. And now, Bhatia and her team are working on expanding the test to detect breast, prostate cancers, and all other types of cancer.

?????????????In a separate but related story, researchers are also working towards a diagnostic methods that do not rely on radiation. While traditional radiation scanners like PET and CT are good at finding cancer, they expose patients to radiation that can create a catch-22 situation where cancer can be induced later in life, especially for younger patients. By potentially inducing cancer in young people, it increases the likelihood that they will have to be exposed to more radiation down the line.

The good news is that scientists have managed to reduce radiation exposure over the past several years without sacrificing image quality. But thanks to ongoing work at the Children’s Hospital of Michigan, the Stanford School of Medicine, and Vanderbilt Children’s Hospital, there’s a potential alternative that involves combining MRI scans with a contrast agent, similar to the one Prof. Bhatia and her MIT group use in their peestick test.

cancer_braintumorAccording to a report published in the journal The Lancet Oncology, the researchers claimed that the new MRI approach found 158 tumors in twenty-two 8 to 33-year-olds, compared with 163 found using the traditional PET and CT scan combo. And since MRIs use radio waves instead of radiation, the scans themselves have no side effects. While the study is small, the positive findings are a step toward wider-spread testing to determine the effectiveness and safety of the new method.

The next step in testing this method will be to study the approach on more children and investigate how it might work in adults. The researchers say physicians are already launching a study of the technique in at least six major children’s hospitals throughout the country. And because the cost of each method could be roughly the same, if the MRI approach proves just as effective yet safer, radiation-free cancer scans are likely to be the way of the future.

cancer_georgiatechAnd last, but not least, there’s a revolutionary new treatment pioneered by researchers at Georgia Tech that relies on engineered artificial pathways to lure malignant cells to their death. This treatment is designed to address brain tumors – aka. Glioblastoma multiform cancer (GBM) – which are particularly insidious because they spread through the brain by sliding along blood vessels and nerve passageways (of which the brain has no shortage of!)

This capacity for expansion means that sometimes tumors developed in parts of the brain where surgery is extremely difficult – if not impossible – or that even if the bulk of a tumor can be removed, chances are good its tendrils would still exist throughout the brain. That is where the technique developed by scientists at Georgia Tech comes in, which involves creating artificial pathways along which cancer can travel to either more operable areas or even to a deadly drug located in a gel outside the body.

cancer_georgiatech1According to Ravi Bellamkonda, lead investigator and chair of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University:

[T]he cancer cells normally latch onto … natural structures and ride them like a monorail to other parts of the brain. By providing an attractive alternative fiber, we can efficiently move the tumors along a different path to a destination that we choose.

The procedure was reported in a recent issue of the journal Nature Materials. It involved Bellamkonda and his team implanting nanofibers about half the size of a human hair in rat brains where GBMs were growing. The fibers were made from a polycaprolactone (PCL) polymer surrounded by a polyurethane carrier and mimicked the contours of the nerves and blood vessels cancer cells like to use as a biological route.

cancer_georgiatech2One end of a fiber was implanted into the tumor inside the brain and the other into a gel containing the drug cyclopamine (which kills cancer cells) outside the brain. After 18 days, enough tumor cells had migrated along the fiber into the gel to shrink the tumor size 93 percent. Not only does Bellamkonda think his technique could be used to relocate and/or destroy cancers, he says he believes it could be used to help people live with certain inoperable cancers as a chronic condition.

In a recent statement, Bellakomba had this to say about the new method and the benefits its offers patients:

If we can provide cancer an escape valve of these fibers, that may provide a way of maintaining slow-growing tumors such that, while they may be inoperable, people could live with the cancers because they are not growing. Perhaps with ideas like this, we may be able to live with cancer just as we live with diabetes or high blood pressure.

Many of today’s methods for treating cancer focus on using drugs to kill tumors. The Georgia Tech team’s approach was engineering-driven and allows cancer to be treated with a device rather than with chemicals, potentially saving the patient many debilitating side effects. Part of the innovation in the technique is that it’s actually easier for tumors to move along the nanofibers than it is for them to take their normal routes, which require significant enzyme secretion as they invade healthy tissue.

cancer_georgiatech3Anjana Jain, the primary author of the study, was also principally responsible for the design of the nanofiber technique. After doing her graduate work on biomaterials used for spinal cord regeneration, she found herself working in Bellamkonda’s lab as a postdoctoral fellow and came up with the idea of routing materials using engineered materials. In a recent statement, she said the following of her idea:

Our idea was to give the tumor cells a path of least resistance, one that resembles the natural structures in the brain, but is attractive because it does not require the cancer cells to expend any more energy.

Extensive testing, which could take up to 10 years, still needs to be conducted before this technology can be approved for use in human patients. In the meantime, Bellamkonda and his team will be working towards using this technology to lure other cancers that like to travel along nerves and blood vessels. With all the advances being made in diagnostics, treatments, and the likelihood of a cure being found in the near future, the 21st century is likely to be the era where cancer becomes history.

Sources: news.cnet.com, (2), (3)

The Future of Medicine: 3D Printing and Bionic Organs!

biomedicineThere’s just no shortage of breakthroughs in the field of biomedicine these days. Whether it’s 3D bioprinting, bionics, nanotechnology or mind-controlled prosthetics, every passing week seems to bring more in the way of amazing developments. And given the rate of progress, its likely going to be just a few years before mortality itself will be considered a treatable condition.

Consider the most recent breakthrough in 3D printing technology, which comes to us from the J.B Speed School of Engineering at the University of Louisville where researchers used a printed model of a child’s hear to help a team of doctors prepare for open heart surgery. Thanks to these printer-assisted measures, the doctors were able to save the life of a 14-year old child.

3d_printed_heartPhilip Dydysnki, Chief of Radiology at Kosair Children’s Hospital, decided to approach the school when he and his medical team were looking at ways of treating Roland Lian Cung Bawi, a boy born with four heart defects. Using images taken from a CT scan, researchers from the school’s Rapid Prototyping Center were able to create and print a 3D model of Roland’s heart that was 1.5 times its actual size.

Built in three pieces using a flexible filament, the printing reportedly took around 20 hours and cost US$600. Cardiothoracic surgeon Erle Austin III then used the model to devise a surgical plan, ultimately resulting in the repairing of the heart’s defects in just one operation. As Austin said, “I found the model to be a game changer in planning to do surgery on a complex congenital heart defect.”

Roland has since been released from hospital and is said to be in good health. In the future, this type of rapid prototyping could become a mainstay for medical training and practice surgery, giving surgeons the options of testing out their strategies beforehand. And be sure to check out this video of the procedure from the University of Louisville:


And in another story, improvements made in the field of bionics are making a big difference for people suffering from diabetes. For people living with type 1 diabetes, the constant need to extract blood and monitor it can be quite the hassle. Hence why medical researchers are looking for new and non-invasive ways to monitor and adjust sugar levels.

Solutions range from laser blood-monitors to glucose-sensitive nanodust, but the field of bionics also offer solutions. Consider the bionic pancreas that was recently trialled among 30 adults, and has also been approved by the US Food and Drug Administration (FDA) for three transitional outpatient studies over the next 18 months.

bionic-pancreasThe device comprises a sensor inserted under the skin that relays hormone level data to a monitoring device, which in turn sends the information wirelessly to an app on the user’s smartphone. Based on the data, which is provided every five minutes, the app calculates required dosages of insulin or glucagon and communicates the information to two hormone infusion pumps worn by the patient.

The bionic pancreas has been developed by associate professor of biomedical engineering at Boston University Dr. Edward Damiano, and assistant professor at Harvard Medical School Dr. Steven Russell. To date, it has been trialled with diabetic pigs and in three hospital-based feasibility studies amongst adults and adolescents over 24-48 hour periods.

bionic_pancreasThe upcoming studies will allow the device to be tested by participants in real-world scenarios with decreasing amounts of supervision. The first will test the device’s performance for five continuous days involving twenty adults with type 1 diabetes. The results will then be compared to a corresponding five-day period during which time the participants will be at home under their own care and without the device.

A second study will be carried out using 16 boys and 16 girls with type 1 diabetes, testing the device’s performance for six days against a further six days of the participants’ usual care routine. The third and final study will be carried out amongst 50 to 60 further participants with type 1 diabetes who are also medical professionals.

bionic_pancreas_technologyShould the transitional trials be successful, a more developed version of the bionic pancreas, based on results and feedback from the previous trials, will be put through trials in 2015. If all goes well, Prof. Damiano hopes that the bionic pancreas will gain FDA approval and be rolled out by 2017, when his son, who has type 1 diabetes, is expected to start higher education.

With this latest development, we are seeing how smart technology and non-invasive methods are merging to assist people living with chronic health issues. In addition to “smart tattoos” and embedded monitors, it is leading to an age where our health is increasingly in our own hands, and preventative medicine takes precedence over corrective.

Sources: gizmag.com, (2)

Ending Cancer: “Canary” and Microscopic Velcro

cancer_cellEnding terminal illness is one of the hallmarks of the 21st century, with advances being made all the time. In recent years, efforts have been particularly focused on findings treatments and cures for the two greatest plagues of the past 100 years – HIV and cancer. But whereas HIV is one of the most infectious diseases to ever be observed, cancer is by far the greater killer. In 2008 alone, approximately 12.7 million cancers were diagnosed (excluding non-invasive cancers) and 7.6 million people died of cancer worldwide.

Little wonder then why so much time and energy is dedicated to ending it; and in recent years, a number of these initiatives have begun to bear fruit. One such initiative comes from the Mayo Clinic, where researchers claim they have developed a new type of software that can help classify cancerous lung nodules noninvasively, thus saving lives and health care costs.

lung-cancer-treatmentIt’s called Computer-aided Nodule Assessment and Risk Yield, or Canary, and a pilot study of the software recently appeared in the April issue of the Journal of Thoracic Oncology. According to the article, Canary uses data from high-resolution CT images of a common type of cancerous nodule in the lung and then matches them, pixel for pixel, to one of nine unique radiological exemplars. In this way, the software is able to make detailed comparisons and then determine whether or not the scans indicate the presence of cancer.

In the pilot study, Canary was able to classify lesions as either aggressive or indolent with high sensitivity, as compared to microscopic analyses of the lesions after being surgically removed and analyzed by lung pathologists. More importantly, it was able to do so without the need for internal surgery to allow a doctor to make a visual examination. This not only ensures that a patient could receive and early (and accurate) diagnosis from a simple CT scan, but also saves a great deal of money by making surgery unnecessary.

velcroAs they say, early detection is key. But where preventative medicine fails, effective treatments need to be available. And that’s where a new invention, inspired by Velcro comes into play. Created by researchers at UCLA, the process is essentially a refined method of capturing and analyzing rogue cancer cells using a Velcro-like technology that works on the nanoscale. It’s called NanoVelcro, and it can detect, isolate, and analyze single cancer cells from a patient’s blood.

Researchers have long recognized that circulating tumor cells play an important role in spreading cancer to other parts of the body. When the cells can be analyzed and identified early, they can offer clues to how the disease may progress in an individual patient, and how to best tailor a personalized cancer treatment. The UCLA team developed the NanoVelcro chip (see above) to do just that, trap individual cancer cells for analysis so that early, non-invasive diagnosis can take place.

NanoVelcro-deviceThe treatment begins with a patient’s blood being pumped in through the NanoVelcro Chip, where tiny hairs protruding from the cancer cells stick to the nanofiber structures on the device’s surface. Then, the scientists selectively cut out the cancer cells using laser microdissection and subject the isolated and purified cancer cells to single cell sequencing. This last step reveals mutations in the genetic material of the cells and may help doctors personalize therapies to the patient’s unique form of cancer.

The UCLA researchers say this technology may function as a liquid biopsy. Instead of removing tissue samples through a needle inserted into a solid tumor, the cancer cells can be analyzed directly from the blood stream, making analysis quicker and easier. They claim this is especially important in cancers like prostate, where biopsies are extremely difficult because the disease often spreads to bone, where the availability of the tissue is low. In addition, the technology lets doctors look at free-floating cancer cells earlier than they’d have access to a biopsy site.

Already, the chip is being tested in prostate cancer, according to research published in the journal Advanced Materials in late March. The process is also being tested by Swiss researchers to remove heavy metals from water, using nanomaterials to cling to and remove impurities like mercury and heavy metals. So in addition to assisting in the war on cancer, this new technology showcases the possibilities of nantechnology and the progress being made in that field.

Sources: news.cnet.com, fastcoexist.com